DC Chemicals

All products / DC9351

Radezolid
CAT. NO. DC9351

Radezolid

Pack sizes and prices

Pack sizePrice
100 mg$750 USDRequest a quote →
250 mg$1,500 USDRequest a quote →
1 g$3,000 USDRequest a quote →

In stock. Contact our team for lead time, shipping and final quotation.

Product overview

Radezolid (RX-1741) is a novel oxazolidinone antibiotic agent. Radezolid is a novel oxazolidinone antibiotic being developed by Rib-X Pharmaceuticals, Inc. for the treatment of serious multi-drug–resistant infections. Radezolid has completed two phase-II clinical trials. One of these clinical trials was for uncomplicated skin and skin-structure infections (uSSSI) and the other clinical trial was for community acquired pneumonia (CAP). From Wikipedia

For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.

Identity and specifications

Catalog numberDC9351
Product nameRadezolid
CAS869884-78-6
Molecular formulaC22H23FN6O3
Molecular weight438.4548
Purity>98%
SMILESCC(NC[C@H]1CN(C2=CC=C(C3=CC=C(CNCC4=CN=NN4)C=C3)C(F)=C2)C(O1)=O)=O

Source-listed specifications; the batch COA applies.

Source and product documents

The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.

DC Chemicals — Radezolid (DC9351)

Source references

[1]. Lemaire S, et al. Cellular pharmacodynamics of the novel biaryloxazolidinone radezolid: studies with infected phagocytic and nonphagocytic cells, using Staphylococcus aureus, Staphylococcus epidermidis, Listeria monocytogenes, and Legionella pneumophila. [2]. Locke JB, et al. Structure-activity relationships of diverse oxazolidinones for linezolid-resistant Staphylococcus aureus strains possessing the cfr methyltransferase gene or ribosomal mutations. Antimicrob Agents Chemother. 2010 Dec;54(12):5337-43.

Related research products